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Abstract
Adult intestinal epithelial stem cells are a promising resource for treatment of intestinal epi-
thelial disorders that cause intestinal failure and for intestinal tissue engineering. We devel-
oped two different animal models to study the implantation of cultured murine and human
intestinal epithelial cells in the less differentiated “spheroid” state and the more differentiated
“enteroid” state into the denuded small intestine of mice. Engraftment of donor cells could
not be achieved while the recipient intestine remained in continuity. However, we were able
to demonstrate successful implantation of murine and human epithelial cells when the graft
segment was in a bypassed loop of jejunum. Implantation of donor cells occurred in a ran-
dom fashion in villus and crypt areas. Engraftment was observed in 75% of recipients for
murine and 36% of recipients for human cells. Engrafted spheroid cells differentiated into
the full complement of intestinal epithelial cells. These findings demonstrate for the first time
successful engraftment into the small bowel which is optimized in a bypassed loop surgical
model.
Introduction
Intestinal failure results from numerous polygenic and monogenic disorders. In its most severe
form, it requires life-long parenteral nutrition and/or allogenic intestinal transplantation, both
treatments that are associated with several complications [1, 2]. While short-bowel syndrome
is the most common cause of intestinal failure, several epithelial disorders result in generalized
malabsorption despite a normal small bowel length [1, 3].
Autologous intestinal stem cell (ISC) based therapy may offer an alternative approach [4–
6]. Prior work in rats included implantation of fresh organoids consisting of crypts with
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surrounding mesenchyme into a denuded small intestinal segment [7, 8]. Subsequently, Lahar
and coworkers reported that myofibroblasts are essential to enable long-term growth of
human small intestinal epithelium in culture [9]. They pre-cultured epithelial cells with added
myofibroblasts on biopolymer scaffolds; these seeded scaffolds gave rise to complex mucosal
structures when implanted subcutaneously into immunocompromised mice (i.e. as hetero-
topic engraftments). Orthotopic implantation of colonic epithelial cells in the partially
denuded colon has also been described: Recent work focused on engrafting ISC-derived colo-
noids or enteroids (epithelium without mesenchyme) into a murine model of dextran sulfate
sodium colitis [4, 5, 10].
The implanted enteroids constituted a single-layered epithelium containing self-renewing
ISCs, progenitor and differentiated lineages. These studies provide preliminary evidence that
enteroids could be used as a source for ISC therapy in intestinal disorders. Of note, successful
engraftment into the murine small bowel has never been reported. This is primarily due to the
technical challenges of denuding and engrafting ISC’s in a small animal model that cannot be
fasted for a prolong period of time. In contrast, in the present study, we describe a novel
method that leads to successful engraftment into the small intestine of recipient mice of
murine and human intestinal mucosal cells that have previously been expanded in in vitro
cultures.
Materials and methods
Animal welfare
All animal studies were approved by the animal research committee at UCLA (ARC #2004–
016 and 2012–077). The UCLA animal facility is accredited by the AALAC. This study was car-
ried out in accordance with the recommendations in the Guide for the Care and Use of Labo-
ratory Animals of the National Institutes of Health.
Procurement of human material
All human tissues used in this study were obtained from de-identified and discarded surgical
specimens following clinical surgical pathology evaluation. This was approved by the UCLA
Institutional Review Board approved procurement and use of surgical samples, which waived
the requirement for informed consent for tissues obtained from the UCLA Translational
Pathology Core Laboratory (IRB #11–002504).
Mouse ISEMF culture
Intestinal subepithelial myofibroblasts (ISEMFs) were isolated from male and female 3–5
week-old C57BL/6 mice and cultured as previously described [11–13]. These were cultured in
DMEM with glutaMAX (Invitrogen, Carlsbad, CA), 10% FBS (Invitrogen), and penicillin/
streptomycin (Invitrogen) with 20 ng/mL EGF (PeproTech, Rocky Hill, NJ), 0.25 U/mL insu-
lin (Sigma, St. Louis, MO), and 10 mg/mL transferrin (Sigma) in 6-well plates. Once confluent,
cells were detached with 0.25% trypsin and 1mM EDTA and serially cultured in T25 or T75
tissue culture flasks. Conditioned medium (CM) was collected from semi-confluent flasks of
ISEMFs every 5 days.
Mouse intestinal crypt culture
Crypts were isolated from 8–12 week-old C57BL/6, C57BL/6-Tg(CAG-EGFP)1Osb/J mice
using a previously reported technique [7, 14]. The structures were cultured in a three-dimen-
sional Matrigel matrix in media containing 50 ng/mL EGF, 100 ng/mL noggin, and 500 ng/mL
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R-spondin-1 alone (“enteroid medium”) or with 1:1 addition of ISEMF-CM and 10 μM
Y27632 Rho-kinase inhibitor (“spheroid medium”). Enteroids were mechanically passaged
using a 25-gauge needle every 5 days. Spheroids were passaged weekly with enzymatic diges-
tion of the matrix in TrypLE followed by mechanical digestion using a 25-gauge needle.
Human ISEMF culture
Intestinal subepithelial myofibroblasts (ISEMFs) were isolated human infant small intestine
and cultured as previously described [9,13] to obtain conditioned medium. In brief, the
ISEMFs were cultured in DMEM with glutaMAX (Invitrogen, Carlsbad, CA), 10% FBS (Invi-
trogen), and penicillin/streptomycin (Invitrogen) with 20 ng/mL EGF (PeproTech, Rocky
Hill, NJ), 0.25 U/mL insulin (Sigma, St. Louis, MO), and 10 μg/mL transferrin (Sigma) in
6-well plates. Once confluent, cells were detached with 0.25% trypsin and 1mM EDTA and
serially cultured in T25 or T75 tissue culture flasks. Conditioned medium (CM) was collected
from semi-confluent flasks of ISEMFs every 5 days.
Human intestinal and crypt culture
Crypts were isolated and cultured as previously described in a three-dimensional Matrigel
matrix in media containing 50 ng/mL EGF, 100 ng/mL noggin, 1 μg/mL R-spondin-1, and 100
ng/mL FGF10 [14, 15]. To make human enteroid culture medium, 10 mM nicotinamide,
2.5 μM CHIR99021, 10 μM SB202190, and 500 nM LY2157299 TGFβ kinase inhibitor were
added and the medium mixed 1:1 with Wnt3a-CM; for human spheroid culture, 10 μM
Y27632 Rho-kinase inhibitor was added and the medium mixed 1:1 with human ISEMF-CM.
Culture wells were passaged every 5 days. Human intestinal crypts were initially cultured as
spheroids, transduced with a GFP expressing lentivirus and frozen at –80˚C [14]. Prior to
implantation, the spheroids were thawed and cultured in human spheroid culture medium
and enteroid culture medium, respectively. Five days later, when these cells had typical spher-
oid or enteroid phenotypes, they were used for implantation.
Preparation of 3 D cell cultures for implantation
For all studies, cultured enteroids or spheroids were released from Matrigel through a three-
minute incubation with TrypLE at 37˚C, mixed with equal volume of 10% FBS and washed
twice with HBSS then suspended in a 1:5 dilution of Matrigel (BD Bioscience, San Jose, CA)
with HBSS and instilled intraluminally. Donor organoids were used for implantation immedi-
ately after harvest and preparation.
Mouse models and surgical techniques
Two days prior to surgery, 12–20 weeks old male and female C57BL/6J mice or NOD-scid
IL2Rgnull (NSG) mice (Jackson Laboratory, Bar Harbor, ME) were placed on a gel diet
(ClearH2O, Portland, ME), oral antibiotic solution consisting of trimethoprim-sulfamethoxa-
zole (Hi-Tech Pharmacal Co., Amityville, NY) mixed 1:100 with drinking water, and raised
wire floors (Ancare, Bellmore, NY). Mice were weighed, anesthetized with inhaled isoflurane,
and given a preoperative subcutaneous injection of ceftriaxone (Hospira, Lake Forest, IL) and
buprenorphine SR (Zoopharm, Windsor, CO).
Their ventral abdominal wall was shaved and cleansed with betadine and alcohol swabs.
Mice were placed on a warming blanket, then sterilely draped. Through a midline laparotomy
and using saline-moistened sterile cotton tipped applicators, a segment of midgut was identi-
fied. The cell implantations were performed into jejunal segments that were in continuity or
Transplantation of cultured murine and human cells into the small intestine
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jejunal segments that were bypassed (for details see below). The abdominal wall and skin were
then closed in interrupted fashion with 6–0 Prolene and 8–0 Vicryl sutures, respectively. Mice
were recovered from anesthesia and kept on oral antibiotic solution for five days. On post-
operative day 1, gel diet was restarted. Animals were maintained on raised wire floors through-
out their post-operative course. Mice were sacrificed on post-operative day 7 and post-opera-
tive day 28, respectively.
In-continuity model. To denude epithelium from a segment of bowel, a 1 cm segment of
midgut was identified and the antimesenteric aspect of the segment clamped with a curved
microvascular clamp to create an isolated pocket (Fig 1A). To remove of the resident epithe-
lium, we modified a method we previously described [7]. Into the pocket, 25 μL of a denuding
solution consisting of 10 mM ethylenediaminetetraacetic acid (EDTA) and 1 mM dithiothrei-
tol (DTT) in phosphate-buffered saline was injected via a 25-gauge needle. After a 2-minute
incubation period, the segment was gently massaged between two moist cotton tipped applica-
tors and the segment was flushed with 5 mL normal saline followed by equal volume of Hanks’
balanced salt solution containing magnesium and calcium (S1A Fig). GFP+ mouse organoids,
cultured enteroids or cultured spheroids were subsequently implanted using an 18 gauge nee-
dle. To retain injected implanted cells temporarily on the luminal side of de-epithelialized seg-
ment, TISSEEL fibrin sealant (Baxter, Deerfield, IL) was applied in the lumen of the
surrounding intestine. Following implantation, the segments were not flushed. The clamps
were removed. The injection site was closed and marked with a stitch of 7–0 Prolene suture.
Bypass model. A 5 cm segment of bowel was exteriorized and an 8 mm side-to-side
entero-enteric anastomosis was performed in interrupted fashion using 9–0 Nylon sutures
Fig 1. (A) Cells were implanted into a jejunal segment (hatched area) that was in continuity of the small intestine by isolating a mucosal
pocket using a semicircular clamp. (B) Alternatively, cells were injected into a bypassed jejunal segment that did not receive the regular
stream of bowel content (hatched area). The arrows show direction of the flow of the ingesta.
https://doi.org/10.1371/journal.pone.0216326.g001
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creating a 5 cm bypass loop of bowel (Fig 1B). Within this segment, a 2-cm segment was par-
tially denuded of mucosa. To do this, the proximal limb of the bypass loop and the mesenteric
vessels supplying the 2 cm segment were successively clamped with atraumatic 10g mini-bull-
dog clamps or temporarily tied with 7–0 Prolene sutures (S2C Fig). Through a 4 mm distal
enterotomy, 200 μL of denuding solution was instilled intraluminally with a mini-bulldog
clamp applied proximal to the enterotomy to keep the denuding solution within the segment.
After a 2-minute incubation period, the segment was gently massaged between two moist cot-
ton tipped applicators (S2D Fig) and the segment was flushed with 5 mL normal saline fol-
lowed by equal volume of Hanks’ balanced salt solution containing magnesium and calcium
(HBSS; S2E Fig) as in the in-continuity model. Cultured enteroids or cultured spheroids were
then injected into the denuded section at a dose of about 2500–4000 cells per recipient using
an 18 gauge needle. The mesenteric and proximal clamps were sequentially removed after the
cell injection. The ends of the segment were constricted with 8–0 Vicryl sutures to limit inflow
of enteric contents but allow passage of mucus out of the segment. The enterotomy was closed
in running fashion with 9–0 Nylon suture. The bowel was returned to the peritoneal cavity
before the abdomen was closed.
Histology and immunohistochemistry
Upon retrieval of surgical samples, the lumen of the bypass segment was flushed with cold
saline, filled with prewarmed Histogel (American MasterTech, Lodi, CA) and fixed in 10%
neutral buffered formalin overnight then stored in 70% ethanol until further histologic pro-
cessing. Specimens were embedded in paraffin and sectioned at 3 μm thickness. Hematoxylin
and eosin (H&E) staining and immunohistochemistry (IHC) were performed per standard
protocol [10,12,14]. Staining was done using antibodies against αSMA (Dako, Carpinteria, CA
and Abcam, Cambridge, MA), GFP (Aves Labs, Tigard, OR), CDX2 (Dako), E-cadherin
(Dako), lysozyme (Abcam), chromogranin A (Immunostar, Hudson, Wisconsin), synaptophy-
sin (Dako), Muc2 (Santa Cruz), and CD10 (Dako). For immunofluorescent stains, appropriate
secondary antibodies conjugated to Alexa Fluor 488 or 594 (Life Technologies, Carlsbad, CA)
were added at 1:200 dilution and nuclei were counterstained with 4’,6-diamidino-2-phenylin-
dole (DAPI, Life Technologies).
Results
Using previously reported methods [9, 13, 14], we cultured murine crypts either in traditional
culture media to produce “enteroids” [15], or in intestinal subepithelial myofibroblast-condi-
tioned medium (ISEMF-CM) to produce “spheroids” [9]. While epithelium in the enteroids
had many features of naturally occurring intestinal crypts, cells forming the spheroidal struc-
tures resulting from the latter growth conditions showed minimal evidence of differentiated
lineages as assessed by immunohistochemistry (Fig 2).
Implantation of murine cells
Adult C57BL/6 recipient mice were used as graft recipients in two different experimental mod-
els that were described above. In one group, we de-epithelialized a semi-circumferential seg-
ment of the intestine wall in the mid-gut region (“in-continuity model,” Fig 1A and S1A Fig).
In another group, we performed an entero-enteric bypass in the midgut and de-epithelialized
the mucosa in the bypassed segment (“bypass model”, Fig 1B and S2A–S2E Fig). In both mod-
els, our de-epithelialization methods produced intestinal luminal areas devoid of mucosal epi-
thelial cells with exposed mucosal mesenchyme while maintaining a relatively intact
submucosal architecture (S2F and S2G Fig). Cultured enteroids or spheroids from C57BL/
Transplantation of cultured murine and human cells into the small intestine
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Fig 2. Characterization of murine enteroids and spheroids. (a-b) Brightfield images in culture; (c-j)
immunohistochemical analysis, (c-d) lysozyme, (e-f) PAS, (g-h) synaptophysin, (i-j) CD10. The majority of the tested
differentiation markers was not visualized in spheroids. Stained structures were obtained from a GFP mouse and
showed expected variability in GFP expression. Scale bars, 50 μm.
https://doi.org/10.1371/journal.pone.0216326.g002
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6-GFP mice were implanted onto the de-epithelialized areas in each group of animals, the
bowel returned into the abdomen and the laparotomy closed. All animals survived the imme-
diate postoperative period.
Seven-day survival of the recipient mice in the in-continuity model group was 17/20 ani-
mals (85%) (Table 1). However, in the “in-continuity” model, we found no engraftment of
GFP cells when we assessed the engraftment areas on post-implant day 7 (n = 20, including 5
implanted with crypts, 5 with spheroids, and 10 with enteroids). Moreover, while numerous
material and various types of implanted cells were used to facilitate engraftment in this model,
none led to discernible implantation and growth of GFP+ mucosal epithelium (Table 1).
In the bypass model group, six mice received donor enteroids, seven mice spheroids. Three
mice died and another two had to be sacrificed; thus 8 of 13 mice were alive on postoperative
day 7 (i.e. a survival rate of 62%) (Table 1). GFP-expressing enteroids were found to be suc-
cessfully engrafted in 3 of 4 recipients (75%) sacrificed on post-operative day 7. Engrafted cells
were in juxtaposition to the α-SMA-positive mesenchymal layer. They formed serial invagina-
tions that appeared to represent early crypt-villus architecture. We confirmed the epithelial
identity of these cells with E-cadherin staining. Engrafted epithelium showed evidence of dif-
ferentiation into the full assortment of differentiated lineages characteristic of small intestinal
mucosa (Fig 3).
When cells from spheroid cultures were implanted into recipients, we found that they also
successfully engrafted in 3 of 4 recipients (75%) sacrificed at one-week post-implantation.
Double-immunofluorescence of the transplanted intestinal segment showed cells staining for
GFP and E-cadherin (Fig 3A). GFP-expressing cells were observed to differentiate into all
intestinal epithelial lineages (Fig 3B–3F). In two animals that had been implanted with spher-
oids, we assessed the long-term viability of the resulting neo-mucosa and the cellular engraft-
ment persisted for four weeks after implantation (Table 1). Based on our histologic
examination, the engrafted cells appeared identical to normal intestinal mucosa (Fig 3G and
3H).
Implantation of human cells
Cultured human enteroids and spheroids showed the same differentiation patterns that we
had observed under identical growth conditions previously [9, 16]. Enteroids contained E-cad-
herin, Lysozyme, Chromogranin A and Muc2-positive cells; spheroids showed no differentia-
tion markers but were Lgr5-positive. Using the same surgical approach, we implanted human
Table 1. Synopsis of all implantation experiments. All surviving recipient mice were sacrificed and examined on postoperative day 7 except two mice implanted with
spheroids that were sacrificed and examined after 28 days (see asterisks).
Implant Method Implanted Cells Number
of Mice
Mice Survived Engraftment Successful
In continuity Murine crypts 5 4 -
In continuity Murine spheroids 5 5 -
In continuity Murine enteroids 10 8 -
Bypass segment Murine spheroids 7 4� 3��
Bypass segment Murine enteroids 6 4 3
Bypass segment Human spheroids 9 5 2
Bypass segment Human enteroids 9 6 2
�Four mice were alive on postoperative 7; two of these mice were sacrificed that day and one was found to have engrafted cells.
��Two of the four mice alive on postoperative day 7 were sacrificed on postoperative day 28 and both were found to have engrafted cells.
https://doi.org/10.1371/journal.pone.0216326.t001
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enteroids and spheroids in immune-deficient NSG mice as recipients. Since the “in-continu-
ity” model have not led successful engraftment using murine cells, we employed only the
entero-enteric bypass model in the human cell engraftment studies. In order to establish the
feasibility and outcome of the procedure, an entero-enteric bypass was performed in 12 mice,
of which 6 (50%) survived to post-implantation day 7. The other six either were found in poor
health and sacrificed per experimental protocol (n = 4) or were found dead (n = 2).
We then engrafted a consecutive series of 18 mice and ultimately had total of 11 mice that
had survived to postoperative day 7. We found the positive engraftment of cultured human
cells was detected in 4 of these 11 mice. (Spheroids, n = 2; enteroids, n = 2; total engraftment
rate = 36%; Table 1; Figs 4 and 5).
We examined those animals that did not survive the first postoperative week. However, it
was not possible to determine with certainty before postoperative day 7 if an actual implanta-
tion of GFP cells had occurred due to the significant histologic alteration of the mucosa that
resulted from the de-epithelialization procedure, the subsequent healing process and the scat-
tered GFP signals emitted by non-engrafted cell fragments.
In both murine and human cell implantations, the engraftment of individual cells appeared to
be a random geographic event. At seven days post-transplantation, the engrafted cells repopulated
the surface of the intestine anywhere between the crypt base and the villus tip (see Figs 3 and 5).
Discussion
With recent advances in ISC expansion and CRISPR/Cas9 editing [15–18] ISC-based therapy
for epithelial disorders using ablation and engraftment techniques such as those presented
Fig 3. Immunofluorescence stains of engrafted GFP murine spheroids in wild type mouse small intestine. (a) one
week after implantation; (b-f) four weeks after implantation: (b) E-cadherin, (c) lysozyme, (d) synaptophysin, (e)
CD10, (f) Muc2. (g-h) H&E stain and GFP immunofluorescence of consecutive slides of engrafted mouse intestine
four weeks post-implantation. Nuclei are counter-stained with 4’,6-diamidino-2-phenylindole (DAPI). Scale bars,
20 μm (a-f) and 50 μm (g-h).
https://doi.org/10.1371/journal.pone.0216326.g003
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here may become possible. Investigators have grown small intestinal and colonic mucosal cells
successfully on biodegradable scaffolds in an attempt to generate a substitute mucosa in in vivo
engraftment models [19]. In contrast, implantation of intestinal epithelial cells onto a native
graft bed in the intestine has rarely been described. Only in the colon, the proof-of-concept
has been demonstrated by transplanting cultured murine colonic epithelium into mice with
DSS-induced colitis with restoration of the colonic epithelial barrier function and reversal of
weight loss [5]. A more recent study described successful engraftment of human colonic orga-
noids into recipient mice after careful chemical and mechanical debridement of the murine
colon wall [10]. In contrast, there have been no studies demonstrating implantation of intesti-
nal mucosal cells into the native small intestine, or engraftment of intestinal mucosal epithe-
lium that is derived from humans into any area of the intestine.
We have previously shown the formation of a neo-epithelium upon the heterotopic implan-
tation of biopolymer scaffolds that were seeded with both epithelial and mesenchymal cells
and then pre-cultured before implantation resulted formation of a neo-epithelium [9]. How-
ever, in the present study, we hypothesized that mesenchyme-free cultured murine and
human small intestinal mucosal epithelium can engraft in a small intestinal section whose
native epithelium has been removed while leaving behind some native mesenchyme cells
below the basement membrane. Our group had previously reported similar studies in which
we removed the resident mucosa in a segment of jejunum and seeded the underlying tissue
with intestinal organoids that had been prepared fresh from donor mucosa [8, 20]. However,
that approach did not involve any in vitro expansion of the pool of donor cells and was there-
fore of limited therapeutic value. Here, we set out to propagate small intestinal mucosal cells in
vitro first and tested if these cultured cells can be engrafted. We experimented with two pheno-
types of epithelial cultures: spheroids–thin-walled, balloon-like structures with lower expres-
sion of epithelial differentiation markers, or enteroids containing ISCs at their crypt-like
budding extensions and differentiated cells at their villus-like domains [14–16, 21]. We dem-
onstrate that murine enteroids and spheroids are both capable of reconstituting the mucosa in
Fig 4. Immunofluorescence stain of engrafted GFP human enteroids in NSG mouse small intestine one week after implantation with anti-E-cadherin
antibodies. Nuclei are counter-stained with DAPI. Scale bar, 50 μm.
https://doi.org/10.1371/journal.pone.0216326.g004
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denuded small intestine. The implanted spheroids, despite their more primitive state in cul-
ture, reconstituted the small intestinal mucosa and differentiated into all the appropriate cell
lineages in vivo. The morphologic features resembled observations we make in our previous
heterotopic implantation model implanting seeded scaffolds under skin of immunocompro-
mised mice [9].
At one-week post-transplantation, the engrafted cells repopulated the surface of the intes-
tine anywhere between the crypt base and the villus tip. This seems to suggest that engraftment
was a random process with implanted cells attaching to the exposed mesenchyme at the first
point of contact. While we harvested organoids, spheroids and enteroids carefully from groups
Fig 5. Immunofluorescence stains of engrafted human GFP spheroids in the small intestine on post-implantation
week 1. (a) E-cadherin, (b) lysozyme, (c) Muc2, (d) chromogranin A and (e) CD10. Nuclei are counterstained blue
with DAPI. Scale bars, 50 μm.
https://doi.org/10.1371/journal.pone.0216326.g005
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of intact multi-cell conglomerates, the preparation and implantation procedure invariably
leads to some fragmentation of these delicate structures. This may explain why we observe
implantation of cells even half way up the villus in some cases (e.g. Fig 5A).
This study provides a first proof-of-concept that a partially ablated small intestinal epithe-
lium can be successfully repopulated with mesenchyme-free cultured epithelial cells. This
methodology could for example be used to convert a jejunal segment that is not capable of
active bile acid or vitamin B12 absorption into a substitute ileum by engrafting it with ileal
cells [7]. Further additional work is needed to develop a clinically applicable method to denude
native small intestinal mucosa.
Our cell transplantation technique led to successful implantation in an entero-enteric
bypass model. The simpler in-continuity model proved ineffective. This may be due to the
higher shear forces that may act on the freshly engrafted cells while the flow of ingesta is still
passing by the transplantation site in the latter model. We attempted to limit this effect by
depositing fibrin as a temporary filler material around the engraftment site. However, this
proved insufficient to ensure engraftment of donor cells. To advance this field, development of
simpler and more effective alternative techniques of transplantation will be required. We pre-
viously used biodegradable scaffolds successfully as a graft bed [9]. However, we believe future
focus ought to be directed at graft bed optimization in the native intestinal tissues without the
use of biopolymers. Yet so far, little is known about the requirements for an optimal graft bed
for intestinal mucosal cells in the small intestine. The previously described methods of chemi-
cal and mechanical deepithelialization are rather crude and carry a certain mortality risk [10].
Furthermore, in the present study, the NSG mice did not tolerate the bypass operation well
and the procedure showed a significant mortality. NSG mice are also not an ideal animal
model for surgical engraftment efforts since they are more likely to succumb to infectious
complications of intestinal surgery due to their immune deficiency. In addition, current cul-
ture techniques require supplementation of recombinant growth factors and any clinical appli-
cation of this transplantation technique in human patients will depend on development of an
allogen-free culture system. Finally, the highly variable effects of the denudation and of the
engraftment in different areas were a shortcoming of this study. We estimate that the engraft-
ment efficiencies for human enteroids and spheroids were under 5% of the denuded mucosal
surface area, respectively. However, it would be desirable to quantify the efficiency of the
engraftment rates for enteroids and spheroids more precisely. This would require extensive
morphometric studies which should be added to future investigations.
Conclusion
This study provides a first proof-of-concept that a partially ablated small intestinal epithelium
can be successfully repopulated with mesenchyme-free cultured murine and human mucosal
epithelial cells. Further additional work is needed to develop a clinically applicable method to
denude native small intestinal mucosa.
Supporting information
S1 Fig. In-continuity model. (a) Denuding of a hemi-circumferential segment of small bowel;
(b) H&E stain of denuded small bowel one week later. The denuded site had been marked
with a large suture (arrow) during the denudement a week prior. The entire epithelium is here
in a state of regeneration. (c-d) absence of positive staining for GFP protein at the engraftment
site, thus no evidence for engraftment of GFP enteroids one week after transplantation.
(TIFF)
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S2 Fig. Entero-enteric bypass model. (a) Loop of ileum exteriorized via midline laparotomy,
(b) entero-enteric anastomosis, (c) temporary ligation of mesenteric vessels and proximal
bowel, and clamping of distal bowel to create a 2 cm isolated segment for denuding, (d)
mechanical denuding using cotton tip applicators after infusion of denuding solution, (e)
flushing denuded segment. (f) H&E section of partially denuded ileum; scale bar, 500 μm, (g)
magnified view of boxed region in (f) demonstrating denuded epithelium.
(TIFF)
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